-
Integrated Sustainability Assessment of the Population-Based Colorectal Cancer Screening Program in Flanders
Sep 9, 2025, 16:22 PM -
Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective
Sep 9, 2025, 16:22 PM -
Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
One Trial, Two Clocks: Coordinating EMA Assessment and Complementary EU HTA Evidence
Sep 9, 2025, 16:22 PM -
Economic and Clinical Impact of Older Adult Vaccination With the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico
Sep 9, 2025, 16:22 PM -
What Affects Quality of Life Most in Oral Cancer Therapy? A Pilot Study of Adherence and Side Effects
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Survival of Patients With HR+/HER2-negative Metastatic Breast Cancer After Treatment With CDK4/6-Inhibitors in Finland
Sep 9, 2025, 16:22 PM -
Analysis of ATC Equivalent Group and Therapeutic Reference Code Distributions Based on Drug Price and Reimbursement Lists in Türkiye Between 2020 and 2025
Sep 9, 2025, 16:22 PM -
Do Short-Term Outcome-Based Payments for Treatments Provide the Same Incremental Net Benefit As List Price Discounts?
Sep 9, 2025, 16:22 PM -
Length of Stay (LOS) and Associated Healthcare Resource Use (HCRU) for a First Infusion of Axi-cel or Lisocel in Second Line for Large B-cell Lymphoma in France: Differences Observed From Comprehensive Hospital Databases
Sep 9, 2025, 16:22 PM -
Overall Survival Adjusted for Subsequent Treatments: A Review of Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Lung Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Registration and Access to Orphan Medicines in Türkiye: A Comparative Study With Poland and Germany
Sep 9, 2025, 16:22 PM -
Updated Projections of HPV Vaccine Coverage Growth in Europe: Are Countries on Track to Meet WHO's 2030 Target?
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Crohn’s Disease Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Out-of-Work Transitions in the European Population With Noncommunicable Diseases
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Transcatheter Valve Replacement Using Valves With RESILIA Tissue for the Treatment of Aortic Stenosis in South Korea
Sep 9, 2025, 16:22 PM -
Sex Differences in Autoimmune Multimorbidity Across 11 Autoimmune Disorders in the Real-World Setting in Germany
Sep 9, 2025, 16:22 PM -
Conceptualizing an Economic Model Structure for Parkinson's Disease
Sep 9, 2025, 16:22 PM -
Insights From a French Postmarketing Authorization Early Access (MA EA) Mechanism: Projecting Clinical and Economic Benefits of Neoadjuvant Nivolumab–Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM